Albireo Pharma logo
Albireo Pharma ALBO

Quarterly report 2022-Q3
added 11-08-2022

report update icon

Albireo Pharma Current Ratio 2011-2026 | ALBO

Annual Current Ratio Albireo Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.39 10.4 7.49 13.1 6.94 13.9 22.7 15.4 16.4 14.2 11.9

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
22.7 2.39 12.3

Quarterly Current Ratio Albireo Pharma

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 1.45 1.99 2.31 2.39 2.58 2.07 2.45 2.74 2.74 2.74 2.74 2.3 2.3 2.3 2.3 2.95 2.95 2.95 2.95 9.19 9.19 9.19 9.19 3.91 3.91 3.91 3.91 0.46 22.2 22.2 25.9 9.75 9.67 9.67 9.67 5.63 4.79 4.79 4.79 3.97 4.07 4.07 4.07 8.2 9.38 9.38 9.38

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
25.9 0.46 5.99

Current Ratio of other stocks in the Biotechnology industry

Issuer Current Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
1.02 - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
1.61 - -24.86 % $ 820 K usaUSA
AbbVie AbbVie
ABBV
3.18 $ 208.84 -2.86 % $ 369 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
3.48 $ 3.52 0.28 % $ 1.05 B canadaCanada
Grifols, S.A. Grifols, S.A.
GRFS
1.67 $ 8.24 -0.12 % $ 6.83 B spainSpain
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
0.889 $ 229.25 0.44 % $ 5 B danmarkDanmark
I-Mab I-Mab
IMAB
8.96 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
3.59 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
0.922 - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
1.34 - -13.47 % $ 169 M franceFrance
Aeterna Zentaris Aeterna Zentaris
AEZS
1.6 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12.4 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.79 - - $ 26.5 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
10.9 - - $ 3.67 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
2.29 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.02 - -1.52 % $ 24.7 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
1.5 $ 74.21 -2.3 % $ 1.43 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
1.65 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
5.93 - -9.65 % $ 45.9 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
1.43 $ 1.41 2.17 % $ 375 M britainBritain
AgeX Therapeutics AgeX Therapeutics
AGE
0.995 - -10.17 % $ 12.2 K usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
2.87 $ 1.51 48.04 % $ 17 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
2.31 - - $ 10.1 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
2.59 - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
6.18 - 0.23 % $ 488 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.04 - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
2.19 - 3.16 % $ 1.9 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
5.04 $ 55.5 -3.04 % $ 10.6 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
2.67 - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
3.34 - 10.36 % $ 9.8 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.74 $ 8.03 2.29 % $ 220 M israelIsrael
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
1.78 $ 14.81 2.63 % $ 2.25 B usaUSA
Altimmune Altimmune
ALT
5.09 $ 3.34 7.05 % $ 294 M usaUSA
BioNTech SE BioNTech SE
BNTX
7.95 $ 91.18 1.97 % $ 27.2 B germanyGermany
Amgen Amgen
AMGN
1.44 $ 347.94 -1.51 % $ 187 B usaUSA
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
4.41 $ 15.61 0.9 % $ 2.1 B canadaCanada
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
1.26 $ 59.6 -2.45 % $ 121 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
0.269 - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
2.35 - -39.0 % $ 4.57 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
2.47 - - $ 867 M germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
2.14 $ 4.14 -2.59 % $ 683 M britainBritain
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
0.507 $ 9.02 -3.84 % $ 1.86 B usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
2.67 - -52.27 % $ 4.45 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
7.92 $ 5.76 1.95 % $ 469 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2.14 - 0.49 % $ 251 B cayman-islandsCayman-islands
AVROBIO AVROBIO
AVRO
15.9 - 1083.1 % $ 745 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
1.31 $ 3.41 1.19 % $ 116 M franceFrance
Biogen Biogen
BIIB
2.63 $ 177.34 -3.5 % $ 26 B usaUSA
Axcella Health Axcella Health
AXLA
1.28 - -16.42 % $ 249 M usaUSA
Axon Enterprise Axon Enterprise
AXON
2.08 $ 412.81 -2.54 % $ 31.3 B usaUSA